Your browser is no longer supported. Please, upgrade your browser.
OCGN [NASD]
Ocugen, Inc.
Index- P/E- EPS (ttm)-0.33 Insider Own0.50% Shs Outstand186.30M Perf Week3.63%
Market Cap1.37B Forward P/E12.17 EPS next Y0.54 Insider Trans-48.40% Shs Float182.53M Perf Month-25.00%
Income-37.50M PEG- EPS next Q-0.03 Inst Own12.50% Short Float23.55% Perf Quarter-26.35%
Sales0.04M P/S32242.64 EPS this Y79.00% Inst Trans63.71% Short Ratio0.65 Perf Half Y2090.00%
Book/sh0.25 P/B26.28 EPS next Y150.30% ROA-119.50% Target Price7.67 Perf Year2584.92%
Cash/sh0.21 P/C30.67 EPS next 5Y- ROE-154.50% 52W Range0.19 - 18.77 Perf YTD259.02%
Dividend- P/FCF- EPS past 5Y70.80% ROI- 52W High-65.00% Beta4.50
Dividend %- Quick Ratio12.00 Sales past 5Y- Gross Margin- 52W Low3451.35% ATR0.97
Employees15 Current Ratio12.00 Sales Q/Q- Oper. Margin- RSI (14)39.91 Volatility8.88% 11.37%
OptionableYes Debt/Eq0.05 EPS Q/Q49.30% Profit Margin- Rel Volume0.34 Prev Close6.54
ShortableYes LT Debt/Eq0.04 EarningsMay 07 BMO Payout- Avg Volume65.90M Price6.57
Recom2.20 SMA20-19.19% SMA50-24.40% SMA20045.29% Volume22,222,134 Change0.46%
Jun-11-21Downgrade ROTH Capital Buy → Neutral $10 → $6
May-07-21Downgrade Cantor Fitzgerald Overweight → Neutral
Feb-09-21Downgrade Chardan Capital Markets Buy → Neutral $0.70 → $13
Feb-04-21Upgrade H.C. Wainwright Neutral → Buy $4.50
Jun-19-21 04:24AM  
Jun-18-21 10:00PM  
08:30PM  
08:30PM  
08:29PM  
08:03PM  
07:04PM  
06:43PM  
06:35PM  
05:06PM  
04:42PM  
04:12PM  
02:52PM  
01:02PM  
11:15AM  
10:02AM  
09:56AM  
Jun-17-21 10:28AM  
10:01AM  
07:53AM  
Jun-16-21 06:30PM  
04:30PM  
02:56PM  
10:00AM  
09:42AM  
07:28AM  
04:55AM  
Jun-15-21 07:23PM  
04:52PM  
02:50PM  
11:47AM  
08:41AM  
07:47AM  
07:30AM  
05:52AM  
Jun-14-21 10:00AM  
08:22AM  
06:00AM  
Jun-12-21 06:08AM  
05:35AM  
Jun-11-21 10:00PM  
02:10PM  
02:03PM  
12:38PM  
11:51AM  
11:50AM  
Jun-10-21 06:32PM  
05:50PM  
03:38PM  
01:47PM  
10:27AM  
10:22AM  
10:22AM  
08:50AM  
08:04AM  
07:35AM  
07:30AM  
Jun-09-21 07:23AM  
Jun-08-21 03:16PM  
Jun-07-21 06:24PM  
Jun-06-21 06:00AM  
Jun-03-21 07:30AM  
05:55AM  
Jun-01-21 08:30AM  
May-29-21 06:30AM  
May-28-21 01:46PM  
May-27-21 09:09AM  
06:01AM  
May-26-21 08:06PM  
May-25-21 08:19AM  
08:10AM  
May-23-21 06:00AM  
May-21-21 09:50AM  
May-20-21 09:26AM  
May-19-21 06:42AM  
May-18-21 09:06AM  
May-15-21 08:01AM  
06:45AM  
May-14-21 11:38AM  
May-13-21 06:30AM  
May-12-21 08:38AM  
May-11-21 06:38AM  
May-10-21 03:42PM  
May-08-21 06:06AM  
May-07-21 10:01PM  
12:24PM  
11:40AM  
10:44AM  
10:37AM  
10:07AM  
07:30AM  
06:45AM  
06:15AM  
06:10AM  
May-06-21 12:32PM  
12:28PM  
09:05AM  
07:30AM  
May-05-21 06:30AM  
May-04-21 07:53PM  
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Subramanian SanjayChief Financial OfficerJun 15Option Exercise0.3431,00010,54076,591Jun 17 05:25 PM
Subramanian SanjayChief Financial OfficerJun 15Sale7.0031,000217,00045,591Jun 17 05:25 PM
Potti ManishDirectorJun 15Sale8.8668,185604,11991,124Jun 17 05:23 PM
Musunuri ShankarChief Executive OfficerJun 08Option Exercise0.3322,8007,524428,800Jun 09 07:22 PM
Musunuri ShankarChief Executive OfficerJun 08Sale10.9822,800250,344406,000Jun 09 07:22 PM
Musunuri ShankarChief Executive OfficerJun 07Option Exercise0.337,7582,560413,758Jun 09 07:22 PM
Musunuri ShankarChief Executive OfficerJun 07Sale10.947,75884,873406,000Jun 09 07:22 PM
Castillo KirstenDirectorJun 07Sale10.0010,000100,00065,000Jun 09 07:21 PM
Kompella UdayDirectorMay 28Option Exercise1.887,19113,519557,865Jun 01 06:10 AM
Kompella UdayDirectorMay 28Sale8.827,19163,417550,674Jun 01 06:10 AM
Fernandes PrabhavathiDirectorMay 25Option Exercise0.9333,50031,08019,500May 27 04:07 PM
Fernandes PrabhavathiDirectorMay 25Sale8.2033,500274,7550May 27 04:07 PM
Subramanian SanjayChief Financial OfficerMay 14Option Exercise0.3431,00010,54076,591May 14 04:58 PM
Subramanian SanjayChief Financial OfficerMay 14Sale8.1831,000253,67345,591May 14 04:58 PM
Tammara VijaySenior Vice PresidentMay 04Option Exercise0.8115,71112,7556,500May 05 08:15 PM
Tammara VijaySenior Vice PresidentMay 04Sale13.6815,711214,9540May 05 08:15 PM
Tammara VijaySenior Vice PresidentMay 03Option Exercise0.464,3171,9864,317May 03 08:53 PM
Musunuri ShankarChief Executive OfficerMay 03Option Exercise0.51195,80999,863601,809May 03 09:00 PM
Kompella UdayDirectorMay 03Sale15.0150,000750,500550,674May 03 09:05 PM
Musunuri ShankarChief Executive OfficerMay 03Sale14.24195,8092,788,320406,000May 03 09:00 PM
Tammara VijaySenior Vice PresidentMay 03Sale16.004,31769,0720May 03 08:53 PM
Potti ManishDirectorMay 03Sale15.0260,000901,20063,429May 05 08:13 PM
Potti ManishDirectorMay 03Sale15.0128,000420,2800May 05 08:13 PM
Kompella UdayDirectorApr 30Option Exercise0.5120,00010,200620,674May 03 09:05 PM
Kompella UdayDirectorApr 30Sale11.5620,000231,200600,674May 03 09:05 PM
Tammara VijaySenior Vice PresidentApr 29Option Exercise0.7529,99122,44212,880May 03 08:53 PM
Subramanian SanjayChief Financial OfficerApr 29Option Exercise2.197,99017,49853,581May 03 09:06 PM
Subramanian SanjayChief Financial OfficerApr 29Sale10.987,99087,73045,591May 03 09:06 PM
Tammara VijaySenior Vice PresidentApr 29Sale10.9729,991328,8810May 03 08:53 PM
Kompella UdayDirectorApr 26Sale11.70350,0004,095,000600,674Apr 28 06:52 PM
Kumar RameshDirectorApr 19Option Exercise0.517,5003,8257,500Apr 21 04:16 PM
Kumar RameshDirectorApr 19Sale5.337,50039,9750Apr 21 04:16 PM
Potti ManishDirectorMar 05Option Exercise0.8428,00023,52028,000Mar 08 08:38 PM
Subramanian SanjayChief Financial OfficerJan 29Option Exercise0.5135,59118,15145,591Feb 01 05:31 PM